# Disparities in end-of-life care and place of death in people with malignant brain tumors—A Swedish registry study

**Authors:** Anneli Ozanne, Joakim Öhlén, Stina Nyblom, Asgeir Store Jakola, Anja Smits, Cecilia Larsdotter

PMC · DOI: 10.1093/nop/npae113 · Neuro-Oncology Practice · 2024-11-11

## TL;DR

This study examines where people with malignant brain tumors in Sweden die and finds significant disparities in end-of-life care and place of death.

## Contribution

The study identifies regional and place-of-death disparities in palliative care utilization for malignant brain tumor patients in Sweden.

## Key findings

- Only 35.6% of patients received an official palliative care status before death.
- Specialized palliative care was rarely used in nursing home deaths (20%).
- Regional differences in hospital versus home death odds were significant.

## Abstract

Malignant brain tumors often lead to death. While improving future treatments is essential, end-of-life care must also be addressed. To ensure equitable palliative care, understanding the place of death is crucial, as disparities may lead to inequity of care. This study aims to identify the place of death in adults with malignant brain tumors in Sweden, and the potential associations with official palliative care status by the ICD-10 code Z51.5, sociodemographic factors, health service characteristics, and healthcare service utilization.

A population-level registry study examined the place of death among adults who died of malignant brain tumors in Sweden from 2013 to 2019. Descriptive statistics, univariable, and multivariable binary logistic regression analyses were performed.

We identified 3,888 adults who died from malignant brain tumors. Of these, 64.4% did not receive an official palliative care status. Specialized palliative care was not utilized in 57.2% at the place of death and in 80% of nursing home deaths. In the last month of life, 53.5% of hospital deaths involved 1 transfer, while 41.8% had 2 or more transfers. The odds ratio (OR) of dying in hospital versus at home was higher, with 2 or more transfers (OR 0.63 [0.40, 0.99]). The OR of dying in a hospital versus at home showed significant regional differences.

Despite the severity of their diagnosis, only a minority of patients utilized specialized palliative services at death, and this varied by the place of death. Significant regional disparities were found between hospital and home deaths, indicating unequal end-of-life palliative care in this patient group.

## Full-text entities

- **Diseases:** death (MESH:D003643), Malignant brain tumors (MESH:D001932)
- **Species:** Homo sapiens (human, species) [taxon 9606]

## Full text

_Full body text omitted from this summary view._ Fetch the complete paper as Markdown: https://tomesphere.com/paper/PMC12137219/full.md

## Figures

2 figures with captions in the complete paper: https://tomesphere.com/paper/PMC12137219/full.md

## References

41 references — full list in the complete paper: https://tomesphere.com/paper/PMC12137219/full.md

---
Source: https://tomesphere.com/paper/PMC12137219